Wird geladen...
ERYTHROPOIETIN: ELUCIDATING NEW CELLULAR TARGETS THAT BROADEN THERAPEUTIC STRATEGIES
Given that erythropoietin (EPO) is no longer believed to have exclusive biological activity in the hematopoietic system, EPO is now considered to have applicability in a variety of nervous system disorders that can overlap with vascular disease, metabolic impairments, and immune system function. As...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2441910/ https://ncbi.nlm.nih.gov/pubmed/18396368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pneurobio.2008.02.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|